Published in
Elsevier, Lancet Gastroenterology and Hepatology, 4(4), p. 296-304, 2019
DOI: 10.1016/s2468-1253(19)30015-9
Links
Tools
Safety and efficacy of stopping tenofovir disoproxil fumarate in patients with chronic hepatitis B following at least 8 years of therapy: a prespecified follow-up analysis of two randomised trials
Journal article published in 2019 by
Maria Buti 
,
David K. Wong,
Edward Gane,
Robert Flisiak,
Michael Manns,
Kelly Kaita,
Harry L. A. Janssen,
Marjoleine Op den Brouw,
Belinda Jump,
Kathryn Kitrinos,
Gerald Crans,
John Flaherty,
Anuj Gaggar,
Patrick Marcellin
,
David K. Wong,
Edward Gane,
Robert Flisiak,
Michael Manns,
Kelly Kaita,
Harry L. A. Janssen,
Marjoleine Op den Brouw,
Belinda Jump,
Kathryn Kitrinos,
Gerald Crans,
John Flaherty,
Anuj Gaggar,
Patrick Marcellin
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 